Screening for diabetes in primary care and CGM, AID advice for providers ...

The use of pulse oximetry screening for asymptomatic newborns at or around 24 hours of life helps identify at-risk infants. The American Academy of Pediatrics (AAP) has recently updated screening ...

Russell Libby, MD, FAAP highlights some key benefits of roflumilast 0.15%, approved in 2024 to treat AD in patients aged 6 years and older. Atopic dermatitis (AD) remains a persistent challenge for ...

Kick off the new year with 8 parenting goals: update vaccines, build healthy habits, enjoy outdoor time, read daily, and prioritize mental health. 8 parenting goals to start the new year strong.

Want to stay up to date with pediatric news? Subscribe to the Contemporary Pediatrics e-newsletter to receive emailed updates regarding new data, pediatric clinical trials, puzzler cases, FDA news, ...

Contemporary Pediatrics' editorial advisory member Russell Libby, MD, FAAP, highlights 2024 FDA approval of epinephrine nasal spray (Neffy) in this video interview. A new needle-free epinephrine ...

Greg Forlenza, MD, highlights data from the CLVer trial that included advanced diabetes technology in newly diagnosed T1D patients. Greg Forlenza, MD, a pediatric endocrinologist at the Barbara Davis ...

Needle-free treatments, such as Neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care. In the pediatric population, it is no ...

Discover expert tips for safe and balanced tech use this holiday season with parental controls, privacy guidance, and social media insights. As the holiday season approaches, many families are excited ...

Health care practitioners are naturally curious about diseases of all kinds, especially those that have remained undiagnosed mysteries. Since the holiday season is upon us, The Contemporary Pediatrics ...

Pregnant women infected with avian influenza face a 90% maternal and 86% infant mortality rate, underscoring the urgent need for pandemic preparedness and protection strategies. Avian influenza virus ...

This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies. For the immunocompromised there is limited efficacy ...